GH
Guardant Health Inc.
$67.42
+$2.95(+4.58%)
48
Overall
40
Value
58
Tech
47
Quality
Market Cap
$7.91B
Volume
2.86M
52W Range
$20.14 - $67.51
Target Price
$59.65
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | $90.6M | $214.4M | $286.7M | $373.7M | $449.5M | $563.9M | $739.0M | ||
| Total Revenue | $90.6M | $214.4M | $286.7M | $373.7M | $449.5M | $563.9M | $739.0M | ||
| COST OF GOODS SOLD | |||||||||
| Cost of Revenue | $43.2M | $-70.7M | $-92.5M | $-122.9M | $156.3M | $227.1M | -- | ||
| GROSS PROFIT | |||||||||
| Gross Profit | $47.4M | $285.1M | $194.2M | $250.7M | $293.2M | $563.9M | $739.0M | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $140.4M | $226.0M | $449.1M | $661.7M | $837.6M | $901.6M | $892.8M | ||
| Research & Development | $50.7M | $86.3M | $149.9M | $263.2M | $373.8M | $367.2M | $347.8M | ||
| Research Expense | $50.7M | $86.3M | $149.9M | $263.2M | $373.8M | $367.2M | $347.8M | ||
| Selling, General & Administrative | $89.7M | $139.7M | $299.3M | $398.5M | $463.8M | $451.0M | $545.1M | ||
| Selling & Marketing Expenses | $53.5M | $78.3M | $106.5M | $191.9M | $299.8M | $295.2M | $364.9M | ||
| General & Administrative Expenses | $36.2M | $61.4M | $192.8M | $206.6M | $164.0M | $155.8M | $180.1M | ||
| Promotion & Advertising | $-223.0K | $1.3M | $1.2M | $2.4M | -- | -- | -- | ||
| Salaries & Wages | $6.9M | -- | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-6.1M | $9.3M | $14.1M | $20.2M | $33.4M | $40.0M | $40.1M | ||
| Depreciation & Amortization | $-6.1M | $9.3M | $14.1M | $20.2M | -- | -- | -- | ||
| Amortization | $-228.0K | $3.3M | $3.3M | $14.2M | $14.3M | $5.9M | $5.9M | ||
| Other Operating Expenses | $-1.6M | $-3.1M | $-4.7M | $-8.2M | -- | $83.4M | -- | ||
| OPERATING INCOME | |||||||||
| Operating income | $-92.9M | $-82.4M | $-254.9M | $-411.0M | $-544.4M | $-564.7M | $-443.6M | ||
| EBITDA | $-76.3M | $-59.4M | $-225.1M | $-359.6M | $-612.3M | $-430.7M | $-387.5M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | $1.3M | $1.2M | $4.8M | $2.6M | $2.6M | $2.6M | $2.6M | ||
| Intinc | $5.3M | $13.7M | $10.2M | $3.9M | $6.1M | $35.4M | $53.7M | ||
| Net Non-Operating Interest Income/Expense | $4.0M | $12.6M | $5.4M | $1.4M | $3.5M | $32.8M | $51.1M | ||
| Other Income/Expense | $-4.7M | $-88.0K | $-3.6M | $-25.2M | $-112.6M | $-53.2M | $42.6M | ||
| Other Special Charges | $4.7M | $88.0K | $3.6M | $25.2M | $-12.8M | $53.2M | $-42.6M | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-83.0M | $-68.5M | $-241.1M | $-381.9M | $-650.9M | $-476.2M | $-432.5M | ||
| Pre-Tax Income | $-84.2M | $-69.7M | $-245.9M | $-384.5M | $-653.4M | $-478.8M | $-435.1M | ||
| INCOME TAX | |||||||||
| Tax Provision | $38.0K | $-1.9M | $379.0K | $300.0K | $1.1M | $685.0K | $1.3M | ||
| NET INCOME | |||||||||
| Net Income | $-85.1M | $-75.7M | $-253.8M | $-405.7M | $-654.6M | $-479.4M | $-436.4M | ||
| Net Income (Continuing Operations) | $-85.1M | $-75.7M | $-253.8M | $-405.7M | $-654.6M | $-479.4M | $-436.4M | ||
| Net Income (Discontinued Operations) | $-85.1M | $-75.7M | $-253.8M | $-405.7M | $-654.6M | $-479.4M | $-436.4M | ||
| Net Income (Common Stockholders) | $-86.2M | $-75.7M | $-253.8M | $-405.7M | $-654.6M | $-479.4M | $-436.4M | ||
| TOTALS | |||||||||
| Total Expenses | $183.6M | $155.3M | $356.6M | $538.8M | $993.9M | $901.6M | $892.8M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $30.4M | $90.6M | $97.5M | $101.3M | $102.2M | $112.0M | $122.7M | ||
| Average Shares Outstanding (Diluted) | $30.4M | $90.6M | -- | $101.3M | $102.2M | $112.0M | $122.7M | ||
| Shares Outstanding | $85.9M | $94.4M | $100.4M | $101.9M | $102.7M | $121.7M | $123.4M | ||
| Basic EPS | -- | $-0.84 | $-2.6 | $-4 | $-6.41 | $-4.28 | $-3.56 | ||
| Basic EPS (Continuing Operations) | -- | $-0.84 | $-2.6 | $-4 | $-6.41 | $-4.28 | $-3.56 | ||
| Diluted EPS | $-2.8 | $-0.84 | $-2.6 | $-4 | $-6.41 | $-4.28 | $-3.56 | ||
| Diluted EPS (Continuing Operations) | $-2.8 | -- | -- | $-4 | $-6.41 | $-4.28 | $-3.56 | ||
| OTHER METRICS | |||||||||
| Accrued Preferred Stock Dividends | $1.1M | $1.1M | -- | -- | -- | -- | -- | ||
| Minority Interests | $-800.0K | $-7.8M | $-7.5M | $-20.9M | -- | -- | -- | ||
| Other Gand A | $36.2M | $61.4M | $192.8M | $206.6M | $164.0M | $155.8M | $180.1M | ||
| Otherunder Preferred Stock Dividend | $1.1M | $1.1M | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $1.1M | $1.1M | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $-4.6M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $53.5M | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GH | $67.42 | +4.6% | 2.86M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |